Iceland· IS-EU/1/22/1706/001
Eladynos
A abaloparatide product containing abaloparatidum inn, registered in Iceland by Theramex Ireland Limited. The same ATC class is registered in 12 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Abaloparatide is registered in 12 of 19 countries.
Countries holding a registration under ATC H05AA04 (abaloparatide), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 8 of them publish a price we can compare per daily dose
Abaloparatide · ATC H05AA04
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Abaloparatidum INN
- Manufacturer
- Theramex Ireland Limited
- Country
- Iceland (IS)
- ATC code
- H05AA04
- ATC class
- Abaloparatide
- Defined daily dose
- 80 mcg, P
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
2 interactions on record for abaloparatide.
Graded by severity as the source publishes them — 2 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Abaloparatide · interactions on record
2 records
- 2 moderate
Most severe, free to view
- CalcipotriolD05AX02moderate
- CalcitriolD05AX03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Abaloparatide in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaELADYNOSTheramex Ireland Limited, Dublin
- United StatesTymlosRadius Health, Inc.
- SpainELADYNOS 80 MICROGRAMOS/DOSIS SOLUCION INYECTABLE EN PLUMA PRECARGADATheramex Ireland Limited
- FinlandEladynosTheramex Ireland Limited
- United KingdomEladynos 80micrograms/40microlitres solution for injection 1.5ml pre-filled pensTheramex HQ UK Ltd
- BelgiumEladynos 80 µg/doseTheramex Ireland
- ItalyELADYNOS*1 penna 1,5 ml 2 mg/mlTHERAMEX IRELAND LIMITED
- NetherlandsEladynos 80 microgram/dosis oplossing voor injectie in een voorgevulde penTheramex Ireland Limited
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Eladynos
- Norway · Eladynos
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c97a03fe-9fb3-4699-9958-96e8235546f7 GET /v1/drugs/c97a03fe-9fb3-4699-9958-96e8235546f7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Stungulyf, lausn í áfylltum lyfjapenna",
"source": "lyfjastofnun",
"atc_raw": "H05AA04",
"marketed": false,
"strength": "80 míkróg/skammt",
"ma_number": "EU/1/22/1706/001",
"substance": "Abaloparatidum INN",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt",
"ma_issued_serial": "44907"
}See everything about abaloparatide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.